Rejuvime Medical: Amy Patterson, FNP-C

Rejuvime Medical in Shreveport, LA, operates under the clinical direction of Amy Patterson, FNP-C, a board-certified family nurse practitioner specializing in metabolic health and hormone optimization. The clinic focuses on evidence-based peptide therapies and hormone interventions designed to address weight management challenges, metabolic dysfunction, and age-related hormonal decline. Patterson brings clinical expertise in prescribing and monitoring GLP-1 receptor agonists and other peptide protocols, with an emphasis on individualized dosing strategies that account for patient response, comorbidities, and long-term sustainability. Rejuvime Medical serves patients throughout northwest Louisiana seeking medical weight loss solutions that extend beyond conventional diet and exercise recommendations, offering pharmacologic support grounded in current endocrinology research.

The clinic's peptide therapy program centers on semaglutide and tirzepatide, two glucagon-like peptide-1 receptor agonists approved for chronic weight management in adults with obesity or overweight with weight-related comorbidities. Semaglutide therapy at Rejuvime Medical follows a structured titration schedule, beginning at lower doses to minimize gastrointestinal side effects while achieving therapeutic appetite suppression and improved glycemic control. Tirzepatide, a dual GIP/GLP-1 receptor agonist, is offered for patients who may benefit from enhanced weight loss outcomes or who have not responded optimally to single-agonist therapy. Patterson evaluates each patient's metabolic profile, including hemoglobin A1c, lipid panels, and thyroid function, before initiating peptide therapy, and conducts regular follow-up assessments to monitor efficacy, adjust dosing, and address any adverse effects. The clinic also integrates hormone optimization services, addressing testosterone deficiency, estrogen imbalance, and thyroid disorders that frequently coexist with metabolic syndrome and contribute to weight gain, fatigue, and reduced quality of life.

Amy Patterson's clinical approach combines pharmacologic intervention with patient education on nutrition, physical activity, and behavioral modification. She conducts comprehensive initial consultations that include body composition analysis, metabolic rate assessment, and detailed medical history review to identify underlying factors contributing to weight gain or hormonal imbalance. Patients receive individualized treatment plans that may include peptide therapy, bioidentical hormone replacement, nutritional supplementing, and lifestyle coaching. Patterson monitors patients through regular in-clinic visits or telehealth consultations, adjusting peptide doses based on weight loss progress, tolerance, and metabolic markers. Her clinical model emphasizes long-term metabolic health rather than rapid weight loss, with protocols designed to preserve lean muscle mass, support metabolic rate, and reduce the risk of weight regain after peptide therapy discontinuation.

Patients at Rejuvime Medical in Shreveport typically begin with a comprehensive evaluation appointment where Patterson reviews medical history, current medications, and weight loss goals. Initial lab work is ordered to assess baseline metabolic and hormonal function, and patients receive education on how GLP-1 agonists work, what to expect during titration, and strategies for managing common side effects such as nausea or constipation. Follow-up visits occur every four to six weeks during the active weight loss phase, with body composition tracking, side effect assessment, and dose adjustments as needed. The clinic provides ongoing support for patients transitioning off peptide therapy, including maintenance protocols and hormone optimization to sustain metabolic improvements. Rejuvime Medical also addresses sexual wellness concerns related to hormonal imbalance, offering testosterone replacement for men with hypogonadism and estrogen or progesterone therapy for women experiencing symptoms of perimenopause or menopause.

Rejuvime Medical's patient base includes individuals from Shreveport, Bossier City, and surrounding areas of northwest Louisiana who have struggled with weight loss through traditional methods or who experience symptoms of hormonal decline such as fatigue, low libido, mood changes, or difficulty losing weight despite diet and exercise efforts. The clinic's telehealth services extend access to patients in rural areas of Louisiana, allowing for remote consultations, prescription management, and lab review without requiring frequent travel to Shreveport. Patterson's clinical practice is informed by ongoing education in peptide therapy, hormone replacement, and metabolic medicine, and she maintains active involvement in professional organizations focused on functional and regenerative medicine. Rejuvime Medical operates with a focus on transparency in treatment costs, realistic outcome expectations, and patient safety, ensuring that peptide and hormone therapies are prescribed only when clinically appropriate and with full informed consent regarding potential risks and benefits.